Involvement of the nitric oxide/CGMP/KATP pathway in antinociception induced by exercise in rats

Life Sciences

Volumn 86, Issue 13-14, 2010, Pages 505-509

  Galdino, Giovane S ^a   Cortes, Steyner F ^a   Duarte, Igor D G ^a   Perez, Andrea C ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antinociception; Exercise; Nitric oxide; Pain

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; AMINOGUANIDINE; CYCLIC GMP; GLIBENCLAMIDE; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE; N(G) PROPYLARGININE; N5 (1 IMINOETHYL)ORNITHINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; GLUTAMIC ACID; MITOCHONDRIAL K(ATP) CHANNEL; POTASSIUM CHANNEL;

ANAEROBIC EXERCISE; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; EXPERIMENTAL TEST; FACE FLICK TEST; MALE; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN THRESHOLD; PHYSICAL TOLERANCE; RAT; SPECTROMETRY; TAIL FLICK TEST; TREADMILL EXERCISE; WISTAR RAT; WITHDRAWAL REFLEX; ANIMAL; BLOOD; CEREBROSPINAL FLUID; METABOLISM; PAIN ASSESSMENT; PHYSIOLOGY; SIGNAL TRANSDUCTION;

RATTUS; RATTUS NORVEGICUS; RODENTIA;

ANIMALS; CYCLIC GMP; GLUTAMIC ACID; MALE; NITRIC OXIDE; NITRITES; PAIN MEASUREMENT; PHYSICAL CONDITIONING, ANIMAL; POTASSIUM CHANNELS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 77950577924     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.02.004     Document Type: Article

References (31)

1. CGMP pathway mediates orofacial antinociception induced by electroacupuncture at the St36 acupoint. Brain Research 2008, 1188:54-60.
2. Black J., Chesher G.B., Starmer G.A., Egger G. The painlessness of the long-distance runner. The Medical Journal of Australian 1979, 1(11):522-523.
3. Casale R., Cazzola M., Arioli G., Gracely R.H., Ceccherelli F., Atzeni F., Stisi S., Cassisi G., Altomonte L., Alciati A., Leardini G., Gorla R., Marsico A., Torta R., Giamberardino M.A., Buskila D., Spath M., Marinangeli F., Bazzichi L., Di Franco M., Biasi G., Salaffi F., Carignola R., Sarzi-Puttini P. Italian Fibromyalgia Network. Non pharmacological treatments in fibromyalgia. Reumatismo 2008, 60(1):59-69.
4. D'amour F.E., Smith D.L. A method for determining loss of pain sensation. Journal of Pharmacology and Experimental Therapeutics 1941, 72(1):74-79.
5. Dominiczak A.F., Bohr D.F. Nitric oxide and its putative role in hypertension. Hypertension 1995, 25(6):1202-1211.
6. Duarte I.D.G., Nakamura M., Ferreira S.H. Peripheral analgesia and activation of the nitric oxide cyclic GMP pathway. European Journal of Pharmacology 1990, 186(2-3):289-293.
7. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Analytical Biochemistry 1982, 126(1):131-138.
8. + channels pathway in the peripheral antinociception of melatonin. European Journal of Pharmacology 2008, 596(1-3):70-76.
9. Hoffmann P., Skarphedinsson J.O., Delle M., Thorén P. Electrical stimulation of the gastrocnemius muscle in the spontaneously hypertensive rat increases the pain threshold: role of different serotonergic receptors. Acta Physiology Scandinavica 1990, 138(2):125-131.
10. Homayoun H., Babaie A., Gharib B., Etminani A., Khavandgar S., Mani A., Dehpour A.R. The involvement of nitric oxide in the antinociception induced by cyclosporin A in mice. Pharmacology Biochemistry and Behavior 2002, 72(1-2):267-272.
11. Janal M., Colt E., Clark W. Pain sensitivity, mood and plasma endocrine levels in man following long distance running: effects of naloxone. Pain 1984, 19(1):13-25.
12. Jesse C.R., Savegnago L., Nogueira C.W. Role of nitric oxide/cyclic GMP/K(+) channel pathways in the antinociceptive effect caused by 2, 3-bis(mesitylseleno)propenol. Life Sciences 2007, 81(25-26):1694-1702.
13. Ji L.L. Antioxidant enzyme response to exercise and aging. Medicine and Sciences in Sports and Exercise 1993, 25(2):225-231.
14. Jonsdottir I.H., Jungersten L., Johansson C., Wennmalm A., Thorén P., Hoffmann P. Increase in nitric oxide formation after chronic voluntary exercise in spontaneously hypertensive rats. Acta Physiologica Scandinavica 1998, 162(2):149-153.
15. Kawano T., Zoga V., Kimura M., Liang M.Y., Wu H.E., Gemes G., McCallum J.B., Kwok W.M., Hogan Q.H., Sarantopoulos C.D. Nitric oxide activates ATP-sensitive potassium channels in mammalian sensory neurons: action by direct S-nitrosylation. Molecular Pain 2009, 5:12.
16. Marek P., Mogil J.S., Sternberg W.F., Panocka I., Liebeskind J.C. N-methyl-d-aspartic acid (NMDA) receptor antagonist MK-801 blocks non-opioid stress-induced analgesia. II. Comparison across three swim-stress paradigms in selectively bred mice. Brain Research 1992, 578(1-2):197-203.
17. Murad F. Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development. The New England Journal of Medicine 2006, 355(19):2003-2011.
18. Neubert J., Widmer C.G., Malphurs W., Rossi H.L., Vierck C.J., Caudle M. Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity. Pain 2005, 116(3):386-395.
19. Nirogi R., Kandikere V., Mudigonda K., Bhyrapuneni G., Muddana N., Saralaya R., Benade V. A simple and rapid method to collect the cerebrospinal fluid of rats and its application for the assessment of drug penetration into the central nervous system. Journal of Neuroscience Methods 2009, 178(1):116-119.
20. Norrbrink Budh C., Lundeberg T. Non-pharmacological pain-relieving therapies in individuals with spinal cord injury: a patient perspective. Complementary Therapies in Medicine 2004, 12(4):189-197.
21. + channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin. Pharmacology Biochemistry and Behavior 2003, 76(1):187-195.
22. Pacheco D.F., Reis G.M.L., Francischi J.N., Castro M.S.A., Perez A.C., Duarte I.D.G. δ-opioid receptor agonist SNC80 elicits peripheral antinociception via δ1 and δ2 receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway. Life Sciences 2005, 78(1):54-60.
23. Perez A.P., Oliveira C.C., Prieto J.G., Ferrando A., Vila L., Alvarez A.I. Quantitative assessment of nitric oxide in rat skeletal muscle and plasma after exercise. European Journal of Applied Physiology 2002, 88:189-191.
24. Pertovaara A., Huopanieme T., Virtanen A., Johansson G. The influence of exercise on dental pain thresholds and the release of stress hormones. Physiology and Behavior 1984, 33(6):923-936.
25. Randall L.D., Sellito J.J. A method for measurement of analgesic activity on inflamed tissue. Archives Internationales de Pharmacodynamie et de Therapie 1957, 111(4):409-419.
26. Sessa W.C., Pritchard K., Seyedi N., Wang J., Hintze T.H. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circulation Research 1994, 74(2):349-353.
27. Shyu B.C., Andersson S.A., Thorén P. Endorphin mediated increase in pain threshold induced by long-lasting exercise in rats. Life Sciences 1982, 30(10):833-840.
28. Soares D.D., Lima N.R.V., Coimbra C.C., Marubayashi U. Evidence that tryptophan reduces mechanical efficiency and running performance in rats. Pharmacology Biochemistry and Behavior 2003, 74(2):357-362.
29. Van Zundert J., Cahana A. Pulsed radiofrequency in chronic pain management: looking for the best use of electrical current. Pain Practice 2005, 5(2):74-76.
30. Willow M., Carmody J., Carroll P. The effects of swimming in mice on pain perception and sleeping time in response to hypnotic drugs. Life Sciences 1980, 26(3):219-224.
31. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16(2):109-110.